WTC
COGT icon

WhitTier Trust Company’s Cogent Biosciences COGT Stock Holding History

WhitTier Trust Company’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.51K Buy
+99
New +$3.66K ﹤0.01% 1198

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

WhitTier Trust Company's COGT Position: Q1 2026 in Review

WhitTier Trust Company opened a new position in Cogent Biosciences (COGT) in Q1 2026: 99 shares worth $3.51K. The stake represents ﹤0.01% of the portfolio and ranks #1198 among its holdings.

305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • WhitTier Trust Company held 99 shares of Cogent Biosciences worth $3.51K as of Q1 2026.
  • Cogent Biosciences was a new WhitTier Trust Company position in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #1198 holding.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.